News

Supplemental benefits, which have been a core value proposition of the Medicare Advantage (MA) program for years, are evolving.

The Covid-19 pandemic ushered in a new era of telemedicine, but it also underscored the limitations of the model. Diagnostic tests and vaccines, which are key to combating the pandemic, need to be administered in-person.

Sadly, we have been surrounded by talk of death for nearly a year.

The platform developed through this partnership will surface key insights from medical records-based real-world data while maintaining data privacy, including COVID-19 vaccine trials.

Flare Capital's Alexandra Mullin and Ian Chiang outline COVID-19's impact on the worsening opioid crisis and how the digital opioid use disorder space is likely to develop over the coming years.